Authors:
Connell, PP
Ignacio, L
Haraf, D
Awan, AM
Halpern, H
Abdalla, I
Nautiyal, J
Jani, AB
Weichselbaum, RR
Vijayakumar, S
Citation: Pp. Connell et al., Equivalent racial outcome after conformal radiotherapy for prostate cancer: A single departmental experience, J CL ONCOL, 19(1), 2001, pp. 54-61
Authors:
Powell, IJ
Carpten, J
Dunston, G
Kittles, R
Bennett, J
Hoke, G
Pettaway, C
Weinrich, S
Vijayakumar, S
Ahaghotu, CA
Boykin, W
Mason, T
Royal, C
Baffoe-Bonnie, A
Bailey-Wilson, J
Berg, K
Trent, J
Collins, F
Citation: Ij. Powell et al., African-American heredity prostate cancer study: A model for genetic research, J NAT MED A, 93(4), 2001, pp. 120-123
Authors:
Jani, AB
Vaida, F
Hanks, G
Asbell, S
Sartor, O
Moul, JW
Roach, M
Brachman, D
Kalokhe, U
Muller-Runkel, R
Ray, P
Ignacio, L
Awan, A
Weichselbaum, RR
Vijayakumar, S
Citation: Ab. Jani et al., Changing face and different countenances of prostate cancer: Racial and geographic differences in prostate-specific antigen (PSA), stage, and grade trends in the PSA era, INT J CANC, 96(6), 2001, pp. 363-371
Authors:
Campbell, T
Blasko, J
Crawford, ED
Forman, J
Hanks, G
Kuban, D
Montie, J
Moul, J
Pollack, A
Raghavan, D
Ray, P
Roach, M
Steinberg, G
Stone, N
Thompson, I
Vogelzang, N
Vijayakumar, S
Citation: T. Campbell et al., Clinical staging of prostate cancer: Reproducibility and clarification of issues, INT J CANC, 96(3), 2001, pp. 198-209
Authors:
Royal, C
Baffoe-Bonnie, A
Kittles, R
Powell, I
Bennett, J
Hoke, G
Pettaway, C
Weinrich, S
Vijayakumar, S
Ahaghotu, C
Mason, T
Johnson, E
Obeikwe, M
Simpson, C
Mejia, R
Boykin, W
Roberson, P
Frost, J
Faison-Smith, L
Meegan, C
Foster, N
Furbert-Harris, P
Carpten, J
Bailey-Wilson, J
Trent, J
Berg, K
Dunston, G
Collins, F
Citation: C. Royal et al., Recruitment experience in the first phase of the African American Hereditary Prostate Cancer (AAHPC) Study, ANN EPIDEMI, 10(8), 2000, pp. S68-S77
Authors:
Al-Awqati, Q
Vijayakumar, S
Takito, J
Hikita, C
Yan, L
Wiederholt, T
Citation: Q. Al-awqati et al., Phenotypic plasticity and terminal differentiation of the intercalated cell: The hensin pathway, EXP NEPHROL, 8(2), 2000, pp. 66-71
Authors:
Michalski, JM
Purdy, JA
Winter, K
Roach, M
Vijayakumar, S
Sandler, HM
Markoe, AM
Ritter, MA
Russell, KJ
Sailer, S
Harms, WB
Perez, CA
Wilder, RB
Hanks, GE
Cox, JD
Citation: Jm. Michalski et al., Preliminary report of toxicity following 3D radiation therapy for prostatecancer on 3DOG/RTOG 9406, INT J RAD O, 46(2), 2000, pp. 391-402
Citation: S. Vijayakumar et al., A node-centric indirect boundary element method: three-dimensional displacement discontinuities, COMPUT STRU, 74(6), 2000, pp. 687-703
Authors:
Asbell, SO
Rajmane, KC
Montesano, AT
Zeitzer, KL
Asbell, MD
Vijayakumar, S
Citation: So. Asbell et al., Prostate-specific antigen and androgens in African-American and white normal subjects and prostate cancer patients, J NAT MED A, 92(9), 2000, pp. 445-449
Authors:
Hikita, C
Vijayakumar, S
Takito, J
Erdjument-Bromage, H
Tempst, P
Al-Awqati, Q
Citation: C. Hikita et al., Induction of terminal differentiation in epithelial cells requires polymerization of hensin by galectin 3, J CELL BIOL, 151(6), 2000, pp. 1235-1246
Authors:
Chung, TDK
Park, II
Ignacio, L
Catchatourian, R
Kopnick, M
Davison, E
Conrad, G
Awan, AM
Crawford, D
Vijayakumar, S
Citation: Tdk. Chung et al., Television and news print media are effective in recruiting potential participants in a prostate cancer chemoprevention trial, INT J CANC, 90(5), 2000, pp. 302-304
Authors:
Wang, H
Huang, E
Dale, W
Campbell, T
Ignacio, L
Kopnick, M
Ray, P
Vijayakumar, S
Citation: H. Wang et al., Self-assessed health-related quality of life in men who have completed radiotherapy for prostate cancer: Instrument validation and its relation to patient-assessed bother of symptoms, INT J CANC, 90(3), 2000, pp. 163-172
Authors:
Mantz, CA
Nautiyal, J
Awan, A
Kopnick, M
Ray, P
Kandel, G
Niederberger, C
Ignacio, L
Dawson, E
Fields, R
Weichselbaum, R
Vijayakumar, S
Citation: Ca. Mantz et al., Potency preservation following conformal radiotherapy for localized prostate cancer: Impact of neoadjuvant androgen blockade, treatment technique, and patient-related factors, CA J SCI AM, 5(4), 1999, pp. 230-236
Authors:
Chen, LM
Ignacio, L
Jacobs, R
Kozloff, M
Telfer, M
Elahi, R
Evans, R
Vijayakumar, S
Citation: Lm. Chen et al., Results of a phase II concurrent chemoradiotherapy study using three-dimensional conformal radiotherapy with cisplatin and oral etoposide in stage III nonsmall-cell lung cancer, RADIAT ON I, 7(1), 1999, pp. 49-53
Authors:
Takito, J
Yan, LB
Ma, J
Hikita, C
Vijayakumar, S
Warburton, D
Al-Awqati, Q
Citation: J. Takito et al., Hensin, the polarity reversal protein, is encoded by DMBT1, a gene frequently deleted in malignant gliomas, AM J P-REN, 46(2), 1999, pp. F277-F289
Authors:
Abdalla, I
Ray, P
Ray, V
Vaida, F
Vijayakumar, S
Citation: I. Abdalla et al., Racial differences in prostate-specific antigen levels and prostate-specific antigen densities in patients with prostate cancer, AM J CL ONC, 22(6), 1999, pp. 537-541